← Open Payments lookup

AMY RICHARDSON: Open Payments

NPI 1972112720 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,035 in 68 payments from 15 companies in 2025. Trend: 2023 $964 · 2024 $1,118 · 2025 $1,035

Food & beverage: $967Education: $68
CompanyPaymentsAmount
ABBVIE INC.17$252
Lilly USA, LLC17$119
Novo Nordisk Inc6$110
Astellas Pharma US Inc2$84
Axsome Therapeutics, Inc.3$78
Sumitomo Pharma America, Inc.3$69
MAYNE PHARMA COMMERCIAL LLC4$65
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$56
PFIZER INC.3$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37

Products named: UBRELVY, Auvelity, ZEPBOUND, MYFEMBREE, VRAYLAR, XIFAXAN, Ozempic, QULIPTA.

Industry payments across MO — which companies pay providers there.